D'Ugo, Domenico
 Distribuzione geografica
Continente #
EU - Europa 3.685
NA - Nord America 3.685
AS - Asia 1.255
AF - Africa 28
SA - Sud America 9
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 5
Totale 8.675
Nazione #
US - Stati Uniti d'America 3.650
DE - Germania 1.207
SE - Svezia 712
IT - Italia 606
CN - Cina 555
SG - Singapore 327
UA - Ucraina 290
IE - Irlanda 223
FR - Francia 220
ID - Indonesia 148
GB - Regno Unito 143
IN - India 84
RU - Federazione Russa 80
TR - Turchia 76
FI - Finlandia 58
BE - Belgio 28
CI - Costa d'Avorio 25
CA - Canada 24
NL - Olanda 18
ES - Italia 17
PL - Polonia 15
CZ - Repubblica Ceca 14
AT - Austria 12
HK - Hong Kong 12
IR - Iran 12
JP - Giappone 11
VN - Vietnam 10
MX - Messico 8
CH - Svizzera 7
DK - Danimarca 7
KR - Corea 6
RO - Romania 6
GR - Grecia 5
LT - Lituania 5
EU - Europa 4
PT - Portogallo 4
TH - Thailandia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AR - Argentina 3
BR - Brasile 3
CL - Cile 3
IL - Israele 3
MD - Moldavia 3
NZ - Nuova Zelanda 3
PK - Pakistan 3
RS - Serbia 3
AU - Australia 2
BD - Bangladesh 2
DZ - Algeria 2
VG - Isole Vergini Britanniche 2
A1 - Anonimo 1
EE - Estonia 1
LU - Lussemburgo 1
MA - Marocco 1
NP - Nepal 1
PA - Panama 1
PH - Filippine 1
Totale 8.675
Città #
Chandler 1.035
Ashburn 280
Singapore 235
Dublin 221
San Mateo 188
Jacksonville 169
Jakarta 147
Wilmington 145
Nanjing 118
Milan 114
Ann Arbor 97
Princeton 89
New York 85
Rome 84
Nürnberg 78
Beijing 73
Izmir 64
Moscow 63
Dearborn 62
Cattolica 61
Munich 58
Marseille 55
Woodbridge 54
Boston 52
Houston 50
Fairfield 47
Verona 43
Zhengzhou 41
Lawrence 39
Los Angeles 37
Nanchang 36
Bremen 35
Boardman 34
Redwood City 34
Lancaster 31
Mountain View 31
Norwalk 31
Brussels 28
Shenyang 26
Abidjan 25
Seattle 23
Tianjin 20
Changsha 19
Hebei 19
Cambridge 16
Augusta 15
Leawood 15
Amsterdam 14
Busto Arsizio 14
Hangzhou 14
Helsinki 14
Kunming 14
Redmond 13
Shanghai 13
Hong Kong 12
London 12
Salò 11
Warsaw 11
Andover 10
Paris 10
Toronto 10
Chicago 9
Falkenstein 9
Jiaxing 9
Washington 9
Berlin 8
Fremont 8
Jinan 8
Ottawa 8
Pune 8
University Park 8
Brno 7
Edinburgh 7
Lanzhou 7
Retamar 7
Vienna 7
Falls Church 6
Guangzhou 6
Hefei 6
Kish 6
Monza 6
Ningbo 6
Nuremberg 6
San Francisco 6
Tokyo 6
Bern 5
Cuauhtémoc 5
Dong Ket 5
Frankfurt am Main 5
Hanoi 5
Santa Clara 5
Bangkok 4
Bari 4
Buk-gu 4
Chengdu 4
Costa Mesa 4
Fuzhou 4
Qingdao 4
Rosignano Marittimo 4
Atlanta 3
Totale 4.732
Nome #
A case-control study comparing methylene blue directed biopsies and random biopsies for detecting pre-cancerous lesions in the follow-up of gastric cancer patients 382
NutriCatt protocol in the enhanced recovery after surgery (ERAS) program for colorectal surgery: the nutritional support improves clinical and cost-effectiveness outcomes. 206
A case-control study on the effect of Apolipoprotein E genotypes on gastric cancer risk and progression 186
Prognostic implications of the lymph node count after neoadjuvant treatment for rectal cancer 163
The Road to Curative Surgery in Gastric Cancer Treatment: A Different Path in the Elderly? 161
Outcomes of clinical T4M0 extra-peritoneal rectal cancer treated with preoperative radiochemtoherapy and surgery. A prospective evalation of a single institutional experience. 137
Outcomes of clinical t4m0 extra-peritoneal rectal cancer treated with preoperative radiochemotherapy and surgery: a prospective evaluation of a single institutional experience. 135
Education and imaging: gastrointestinal: videocapsule retention: rationale for surgical indication 124
cDNA-Microarray Analysis as a New Tool to Predict Lymph Node Metastasis in Gastric Cancer 124
R0 resection in the treatment of gastric cancer: room for improvement 118
Ratio of metastatic lymph nodes: impact on staging and survival of gastric cancer 113
Harlequin Syndrome 111
7-Year survival results of perioperative chemotherapy with epidoxorubicin, etoposide, and cisplatin (EEP) in locally advanced resectable gastric cancer: up-to-date analysis of a phase-II study 109
A) Gastric surgery as a long-term risk factor for malignant lesions of the larynx. 104
The impact of surgical delay on resectability of colorectal cancer: An international prospective cohort study 103
Neo-adjuvant chemo(radio)therapy in gastric cancer: Current status and future perspectives 103
Large bowel auto-amputation and passage of a colon 'cast' after left hemicolectomy 102
Prognostic implications of the lymph node count after neoadjuvant treatment for rectal cancer 100
Surgery in COVID-19 patients: Operational directives 98
null 96
Prognostic value of preoperative staging in gastric cancer 95
Susceptibility to Helicobacter pylori infection: results of an epidemiological investigation among gastric cancer patients 94
Determinants of surgical morbidity in gastric cancer treatment 93
Prognostic Value of Preoperative Staging in Gastric Cancer 91
Acute pancreatitis associated with primary hyperparathyroidism 91
Metastatic lymph node ratio: a new staging system for gastric cancer 91
Therapeutic implications of mesenchymal stem cells in liver injury 90
Giant inflammatory polyposis as the first manifestation of inflammatory bowel disease 89
Preoperative therapy and long-term survival in gastric cancer: One size does not fit all 89
Do perioperative blood transfusions influence prognosis of gastric cancer patients? Analysis of 927 patients and interactions with splenectomy 88
Prognostic factors and outcomes in Italian patients undergoing curative gastric cancer surgery 87
Transanal Total Mesorectal Excision vs Laparoscopic Total Mesolectal Excision in the Treatment of Low and Middle Rectal Cancer: A Propensity Score Matching Analysis. 86
Prognostic implications of the lymph node count after neoadjuvant treatment for rectal cancer 85
The prognostic role of perioperative allogeneic blood transfusions in gastric cancer patients undergoing curative resection: A systematic review and meta-analysis of non-randomized, adjusted studies 84
The gut microbiota and colorectal surgery outcomes: facts or hype? A narrative review 84
Preoperative chemotherapy in gastric cancer: expanding the indications, limiting the overuse 81
REGATTA trial: a call for the USA and Europe 81
Perioperative chemotherapy for gastric cancer: how should we measure the efficacy? 80
Do perioperative blood transfusions influence prognosis of gastric cancer patients? Analysis of 927 patients and interactions with splenectomy 79
Does a minimum number of 16 retrieved nodes affect survival in curatively resected gastric cancer? 79
Follow-Up After Gastrectomy for Cancer: An Appraisal of the Italian Research Group for Gastric Cancer 76
Intraoperative esophageal manometry in surgical treatment of achalasia: a reappraisal. 75
Tumor size as a prognostic factor in patients with stage IIa colon cancer 75
Limited lymph node dissection and metastatic lymph node ratio: a wave of trust 71
The SIC-GIRCG 2013 Consensus Conference on Gastric Cancer 71
Risk factors for wound complications in patients undergoing primary closure of the perineal defect after total proctectomy 71
D1-plus vs D2 nodal dissection in gastric cancer: A propensity score matched comparison and review of published literature 71
The role of local excision in rectal cancer after complete response to neoadjuvant treatment 70
The "Lazio Network" experience. The first Italian regional research group on the Enhanced Recovery After Surgery (ERAS) program. A collective database with 1200 patients in 2016-2017 70
The learning curve of TaTME for mid-low rectal cancer: a comprehensive analysis from a five-year institutional experience 70
Follow-up: the evidence 69
Preoperative treatment and surgery in gastric cancer: friends or foes? 68
Gastric cancer: Current status of lymph node dissection 68
3D pelvimetry and biometric measurements: a surgical perspective for colorectal resections 67
Krukenberg tumors: Seed, route and soil 66
Prognostic implications of the lymph node count after neoadjuvant treatment for rectal cancer 66
The INTERACT Trial: Long-term results of a randomised trial on preoperative capecitabine-based radiochemotherapy intensified by concomitant boost or oxaliplatin, for cT2 (distal)-cT3 rectal cancer 65
Impact of the latest TNM classification for gastric cancer: retrospective analysis on 94 D2 gastrectomies. 62
Preoperative chemotherapy in gastric cancer: expanding the indications, limiting the overuse 62
Synchronous gastric adenocarcinoma and MALT lymphoma in a patient with H. pylori infection. Could the two neoplasms share a common pathogenesis? 61
Transesophageal echocardiographic assessment of hemodynamic function during laparoscopic cholecystectomy in healthy patients. 61
Association between colorectal cancer and streptococcus gallolyticus subsp. pasteuranus (former s. bovis) endocarditis: Clinical relevance and cues for microbiota science. case report and review of the literature 61
Italian multi-society modified Delphi consensus on the definition and management of anastomotic leakage in colorectal surgery 59
One-year evaluation of anorectal functionality and quality of life in patients affected by mid-to-low rectal cancer treated with transanal total mesorectal excision 59
Towards the goal of r0 resection in locally advanced gastriccancer through the path of neoadjuvant chemotherapy e impact of tumour downstaging on survival in a single series. 58
Impact of Diagnostic laparoscopy on the managment of gastic cancer: prospective study of 120 consecutive patients with primary gastric adenocarcinoma 58
Long term follow up of a pilot study with neoadjuvant EEP ( epidoxorubicin, Etoposide and Cisplatin) in gastric cancer. 58
Beyond the Guidelines: The Grey Zones of the Management ofGastric Cancer. Consensus Statements from the Gastric CancerItalian Network (GAIN) 58
Development of the PERI-Gastric (PEritoneal Recurrence Index) and PERI-Gram (Peritoneal Recurrence Index NomoGRAM) for predicting the risk of metachronous peritoneal carcinomatosis after gastrectomy with curative intent for gastric cancer 58
Updates on surgical management of advanced gastric cancer: new evidence and trends. Insights from the First International Course on Upper Gastrointestinal Surgery--Varese (Italy), December 2, 2011 57
Achieving high quality standards in laparoscopic colon resection for cancer: A Delphi consensus-based position paper 55
One-year evaluation of anorectal functionality and quality of life in patients affected by mid-to-low rectal cancer treated with transanal total mesorectal excision 55
Nutricatt protocol improves body composition and clinical outcomes in elderly patients undergoing colorectal surgery in eras program: A retrospective cohort study 55
Feasibility of discharge within 72 hours of major colorectal surgery: lessons learned after 5 years of institutional experience with the ERAS protocol 55
Enhanced Recovery Program for Colorectal Surgery: a Focus on Elderly Patients Over 75 Years Old 54
Totally laparoscopic right colectomy versus laparoscopically assisted right colectomy: a propensity score analysis 53
Fashioning enterotomy closure after totally laparoscopic ileocolic anastomosis for right colon cancer: a multicenter experience 53
A word for equity: the long road ahead 53
Surgical issues after neoadjuvant treatment for gastric cancer 52
Image of the month--quiz case. 52
One-year evaluation of anorectal functionality and quality of life in patients affected by mid-to-low rectal cancer treated with transanal total mesorectal excision 52
3D MRI segmentation and 3D circumferential resection margin evaluation for a standard rectal cancer assessment 51
Laparoscopic staging of gastric cancer: an overview. 51
Neoadjuvant chemotherapy and ongoing-trials 50
Follow-up after gastrectomy for cancer: an appraisal of the italian research group for gastric cancer 49
A detailed analysis of the recurrence timing and pattern after curative surgery in patients undergoing neoadjuvant therapy or upfront surgery for gastric cancer 49
Impact of the COVID-19 Pandemic on Enhanced Recovery After Surgery (ERAS) Application and Outcomes: Analysis in the “Lazio Network” Database 48
Imagine a world without cancer 48
Neoadjuvant chemotherapy in gastric carcinoma 48
Could the conservative approach be considered safe in the treatment of locally advanced rectal cancer in case of a clinical near-complete or complete response? A retrospective analysis 48
Quality Over Volume: Modeling Centralization of Gastric Cancer Resections in Italy 48
Chimera fully covered self-expandable metal stent for refractory esophageal anastomotic leak 47
Ratio-based staging systems are better than the 7th and 8th editions of the TNM in stratifying the prognosis of gastric cancer patients: A multicenter retrospective study 46
Global updates in the treatment of gastric cancer: a systematic review. Part 1: staging, classification and surgical treatment 45
Risk factors for wound complications in patients undergoing primary closure of the perineal defect after total proctectomy 43
Long-term outcomes in ypT0 rectal cancers: An international multi-centric investigation on behalf of Italian Society of Surgical Oncology Young Board (YSICO) 43
Mid-transverse colon cancer and extended versus transverse colectomy: Results of the Italian society of surgical oncology colorectal cancer network (SICO CCN) multicenter collaborative study 43
Long-term follow-up of a pilot phase II study with neoadjuvant epidoxorubicin, etoposide and cisplatin in gastric cancer 43
Thyroid cancer in suppressed contralateral lobe of patients with hot thyroid nodule 43
Prognostic Indicators in Stage IV Surgically Treated Gastric Cancer Patients: A Retrospective Multi-Institutional Study 42
Totale 7.947
Categoria #
all - tutte 41.748
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.748


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020605 0 0 0 0 62 67 136 23 89 70 95 63
2020/2021909 35 71 6 67 78 68 137 6 197 78 137 29
2021/20221.112 167 62 17 129 33 16 15 195 34 62 190 192
2022/20232.554 337 336 191 418 154 318 104 189 350 27 96 34
2023/20241.168 58 336 31 59 41 132 70 21 18 80 140 182
2024/2025688 48 71 242 195 132 0 0 0 0 0 0 0
Totale 8.973